Delivery Order SPE2DB22D1202-SPE2DB25FVLL8
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $226,802.34 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions to the prime contractor, which operates from its corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $40,205.76 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, awarded on September 10, 2025, with an ultimate completion date of September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award utilized competitive...
- The Defense Logistics Agency awarded a delivery order valued at $2,147.29 to AmerisourceBergen Drug Corp for pharmaceutical products and services. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $4,467.35 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 6, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,561.20 to AmerisourceBergen Drug Corp on September 13, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $76,047.40 to AmerisourceBergen Drug Corp on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $1 billion ceiling through December 2026. The vendor, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $77,463.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, effective through August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The award is non-set-aside and was competitively...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,181.69 to AmerisourceBergen Drug Corp on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999.9 million through December 2026. The delivery order will be fulfilled from...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,735.57 to AmerisourceBergen Drug Corp for pharmaceutical and medical supplies under a non-competitive, firm fixed-price contract. The award was issued on April 10, 2025, with an ultimate completion date of April 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLL8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,225.52 to AmerisourceBergen Drug Corp for Emporphed 50 mg/10 mL vials on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supplies pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal healthcare vendor, particularly for military and veteran healthcare systems. The company's federal contracting portfolio demonstrates extensive experience fulfilling medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. Through its DLA prime vendor agreement, the company supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's role in the Defense Logistics Agency's Medical Supply Chain, providing pharmaceutical products needed to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/16/25 |